+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Middle East Imaging Biomarkers Market Size, Share & Trends Analysis Report by Biomarkers (Molecular/Nuclear Biomarkers), Imaging Technology, Application, End Use, Country with Growth Forecasts, 2025-2033

  • PDF Icon

    Report

  • 120 Pages
  • November 2025
  • Region: Middle East
  • Grand View Research
  • ID: 6214519
REQUEST CUSTOMIZATION
Description Jump to:

Market Size & Trends

The Middle East imaging biomarkers market size was estimated at USD 413.74 million in 2024 and is projected to reach USD 1.13 billion by 2033, growing at a CAGR of 12.27% from 2025 to 2033. The expansion of advanced imaging infrastructure (MRI, PET/CT) and the greater adoption of biomarker-driven clinical pathways are shifting care from empiric to data-driven approaches.

This structural shift-driven by national healthcare strategies, increased public and private healthcare spending, and programs aimed at attracting clinical trials-creates a growing addressable market for imaging biomarkers used in oncology, neurology, and cardiology.

The growing prevalence of chronic and lifestyle-related diseases is one of the most significant drivers of the Middle East imaging biomarkers industry. The region has seen a rapid rise in cancer, cardiovascular, and neurological disorders due to aging populations, sedentary lifestyles, and dietary changes. According to WHO data, noncommunicable diseases account for over 70% of total deaths in GCC countries, increasing the need for early detection and precise diagnosis. Imaging biomarkers-used in PET, MRI, and CT modalities-play a vital role in identifying disease progression at the molecular levels. This surge in chronic disease prevalence has, therefore, heightened demand for advanced imaging technologies that rely on biomarker data for early and accurate diagnosis.

Increasing healthcare expenditure and infrastructure development are also accelerating market growth. Countries such as Saudi Arabia, the UAE, and Qatar are investing heavily in advanced diagnostic centers, imaging equipment, and hospital modernization as part of their national health transformation programs. For example, Saudi Arabia’s Vision 2030 allocates substantial funds to expand digital and diagnostic healthcare capabilities, while the UAE continues to position itself as a regional hub for precision medicine and advanced diagnostics. This sustained increase in healthcare spending-estimated to grow at over 7% annually across the GCC-enhances accessibility to imaging biomarker technologies and fuels adoption across both public and private sectors.

Middle East Imaging Biomarkers Market Report Segmentation

This report forecasts revenue growth and provides an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this report, the analyst has segmented the Middle East imaging biomarkers market report based on biomarkers, imaging technology, application, end use, and country:

Biomarkers Outlook (Revenue, USD Million, 2021-2033)

  • Anatomical biomarkers
  • Functional biomarkers
  • Molecular/Nuclear Biomarkers
  • Quantitative Imaging Biomarkers
  • Others

Imaging Technology Outlook (Revenue, USD Million, 2021-2033)

  • MRI
  • CT
  • PET
  • SPECT
  • Ultrasound
  • Others

Application Outlook (Revenue, USD Million, 2021-2033)

  • Diagnostics
  • Drug Discovery & Development
  • Personalized Medicine
  • Disease Risk Assessment
  • Others

End Use Outlook (Revenue, USD Million, 2021-2033)

  • Hospitals
  • Diagnostic/imaging centers
  • Pharmaceutical and Biotech Companies
  • Others

Country Outlook (Revenue, USD Million, 2021-2033)

  • Middle East

Why should you buy this report?

  • Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This report addresses:

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segment and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listings for you to stay ahead of the curve

This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.2.1. Biomarkers
1.2.2. Imaging Technology
1.2.3. Application
1.2.4. End Use
1.3. Information analysis
1.4. Market formulation & data visualization
1.5. Data validation & publishing
1.6. Information Procurement
1.6.1. Primary Research
1.7. Information or Data Analysis
1.8. Market Formulation & Validation
1.9. Market Model
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Rising demand for early diagnosis and personalized medicine
3.2.1.2. Advancements in imaging and molecular biomarker technologies
3.2.1.3. Regulatory approvals supporting clinical adoption
3.2.2. Market Restraint Analysis
3.2.2.1. High cost of imaging equipment and diagnostic tests
3.3. Industry Analysis Tools
3.3.1. Porter's Five Forces Analysis
3.3.2. PESTEL Analysis
3.3.3. COVID-19 Impact Analysis
Chapter 4. Middle East Imaging Biomarkers Market: Biomarkers Business Analysis
4.1. Segment Dashboard
4.2. Middle East Imaging Biomarkers Market Biomarkers Movement Analysis
4.3. Middle East Imaging Biomarkers Market Size & Trend Analysis, by Biomarkers, 2021 to 2033(USD Million)
4.4. Anatomical Biomarkers
4.4.1. Anatomical Biomarkers Market Estimates and Forecasts, 2021-2033 (USD Million)
4.5. Functional Biomarkers
4.5.1. Functional Biomarkers Market Estimates and Forecasts, 2021-2033 (USD Million)
4.6. Molecular/Nuclear Biomarkers
4.6.1. Molecular/Nuclear Biomarkers Market Estimates and Forecasts, 2021-2033 (USD Million)
4.7. Quantitative Imaging Biomarkers
4.7.1. Quantitative Imaging Biomarkers Market Estimates and Forecasts, 2021-2033 (USD Million)
4.8. Others
4.8.1. Others Market Estimates and Forecasts, 2021-2033 (USD Million)
Chapter 5. Middle East Imaging Biomarkers Market: Imaging Technology Business Analysis
5.1. Segment Dashboard
5.2. Middle East Imaging Biomarkers Market Imaging Technology, Movement Analysis
5.3. Middle East Imaging Biomarkers Market Size & Trend Analysis, by Imaging Technology, 2021 to 2033(USD Million)
5.4. MRI
5.4.1. MRI Market Estimates and Forecasts, 2021-2033 (USD Million)
5.5. CT
5.5.1. CT Market Estimates and Forecasts, 2021-2033 (USD Million)
5.6. PET
5.6.1. PET Market Estimates and Forecasts, 2021-2033 (USD Million)
5.7. SPECT
5.7.1. SPECT Market Estimates and Forecasts, 2021-2033 (USD Million)
5.8. Ultrasound
5.8.1. Ultrasound Market Estimates and Forecasts, 2021-2033 (USD Million)
5.9. Others
5.9.1. Others Market Estimates and Forecasts, 2021-2033 (USD Million)
Chapter 6. Middle East Imaging Biomarkers Market: Application Business Analysis
6.1. Segment Dashboard
6.2. Middle East Imaging Biomarkers Market Application Movement Analysis
6.3. Middle East Imaging Biomarkers Market Size & Trend Analysis, by Application, 2021 to 2033(USD Million)
6.4. Diagnostics
6.4.1. Diagnostics Market Estimates and Forecasts, 2021-2033 (USD Million)
6.5. Drug Discovery & Development
6.5.1. Drug Discovery & Development Market Estimates and Forecasts, 2021-2033 (USD Million)
6.6. Personalized Medicine
6.6.1. Personalized Medicine Market Estimates and Forecasts, 2021-2033 (USD Million)
6.7. Disease Risk Assessment
6.7.1. Disease Risk Assessment Market Estimates and Forecasts, 2021-2033 (USD Million)
6.8. Others
6.8.1. Others Market Estimates and Forecasts, 2021-2033 (USD Million)
Chapter 7. Middle East Imaging Biomarkers Market: End Use Business Analysis
7.1. Segment Dashboard
7.2. Middle East Imaging Biomarkers Market End Use Movement Analysis
7.3. Middle East Imaging Biomarkers Market Size & Trend Analysis, by End Use, 2021 to 2033(USD Million)
7.4. Hospitals
7.4.1. Hospitals Market Estimates and Forecasts, 2021-2033 (USD Million)
7.5. Diagnostic/imaging centers
7.5.1. Diagnostic/imaging centers Market Estimates and Forecasts, 2021-2033 (USD Million)
7.6. Pharmaceutical and Biotech Companies
7.6.1. Pharmaceutical and Biotech Companies Market Estimates and Forecasts, 2021-2033 (USD Million)
7.7. Others
7.7.1. Others Market Estimates and Forecasts, 2021-2033 (USD Million)
Chapter 8. Middle East Imaging Biomarkers Market: Country Estimates & Trend Analysis by Biomarkers, Imaging Technology, Application & End Use
8.1. Country Dashboard
8.2. Market Size & Forecasts and Trend Analysis, 2021 to 2033
8.3. Middle east
8.3.1. Middle East Imaging Biomarkers Market Estimates and Forecasts, 2021-2033 (USD Million)
8.3.2. Saudi Arabia
8.3.2.1. Key Country Dynamics
8.3.2.2. Competitive Scenario
8.3.2.3. Regulatory Framework
8.3.2.4. Saudi Arabia Imaging Biomarkers Market Estimates and Forecasts, 2021-2033 (USD Million)
8.3.3. UAE
8.3.3.1. Key Country Dynamics
8.3.3.2. Competitive Scenario
8.3.3.3. Regulatory Framework
8.3.3.4. UAE Imaging Biomarkers Market Estimates and Forecasts, 2021-2033 (USD Million)
8.3.4. Kuwait
8.3.4.1. Key Country Dynamics
8.3.4.2. Competitive Scenario
8.3.4.3. Regulatory Framework
8.3.4.4. Kuwait Imaging Biomarkers Market Estimates and Forecasts, 2021-2033 (USD Million)
8.3.5. Oman
8.3.5.1. Key Country Dynamics
8.3.5.2. Competitive Scenario
8.3.5.3. Regulatory Framework
8.3.5.4. Oman Imaging Biomarkers Market Estimates and Forecasts, 2021-2033 (USD Million)
8.3.6. Qatar
8.3.6.1. Key Country Dynamics
8.3.6.2. Competitive Scenario
8.3.6.3. Regulatory Framework
8.3.6.4. Qatar Imaging Biomarkers Market Estimates and Forecasts, 2021-2033 (USD Million)
Chapter 9. Competitive Landscape
9.1. Participant Categorization
9.2. Strategy Mapping
9.3. Company Market Position Analysis, 2024
9.4. Participant’s Overview
9.4.1. GE HealthCare
9.4.1.1. Overview
9.4.1.2. Financial Performance
9.4.1.3. Biomarkers Benchmarking
9.4.1.4. Strategic Initiatives
9.4.2. FUJIFILM Holdings Corporation
9.4.2.1. Overview
9.4.2.2. Financial Performance
9.4.2.3. Biomarkers Benchmarking
9.4.2.4. Strategic Initiatives
9.4.3. Siemens Healthineers AG
9.4.3.1. Overview
9.4.3.2. Financial Performance
9.4.3.3. Biomarkers Benchmarking
9.4.3.4. Strategic Initiatives
9.4.4. Lunit Inc.
9.4.4.1. Overview
9.4.4.2. Financial Performance
9.4.4.3. Biomarkers Benchmarking
9.4.4.4. Strategic Initiatives
9.4.5. Median Technologies
9.4.5.1. Overview
9.4.5.2. Financial Performance
9.4.5.3. Biomarkers Benchmarking
9.4.5.4. Strategic Initiatives
9.4.6. BioClinica Inc.
9.4.6.1. Overview
9.4.6.2. Financial Performance
9.4.6.3. Biomarkers Benchmarking
9.4.6.4. Strategic Initiatives
9.4.7. ICON plc
9.4.7.1. Overview
9.4.7.2. Financial Performance
9.4.7.3. Biomarkers Benchmarking
9.4.7.4. Strategic Initiatives
9.4.8. Bracco
9.4.8.1. Overview
9.4.8.2. Financial Performance
9.4.8.3. Biomarkers Benchmarking
9.4.8.4. Strategic Initiatives
9.4.9. Philips Healthcare
9.4.9.1. Overview
9.4.9.2. Financial Performance
9.4.9.3. Biomarkers Benchmarking
9.4.9.4. Strategic Initiatives
List of Tables
Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 Middle East imaging biomarkers market, by biomarkers, 2021-2033 (USD Million)
Table 4 Middle East imaging biomarkers market, by imaging technology, 2021-2033 (USD Million)
Table 5 Middle East imaging biomarkers market, by application, 2021-2033 (USD Million)
Table 6 Middle East imaging biomarkers market, by End Use, 2021-2033 (USD Million)
Table 7 Middle East imaging biomarkers market, by country, 2021-2033 (USD Million)
Table 8 Saudi Arabia imaging biomarkers market, by biomarkers, 2021-2033 (USD Million)
Table 9 Saudi Arabia imaging biomarkers market, by imaging technology, 2021-2033 (USD Million)
Table 10 Saudi Arabia imaging biomarkers market, by application, 2021-2033 (USD Million)
Table 11 Saudi Arabia imaging biomarkers market, by End Use, 2021-2033 (USD Million)
Table 12 UAE imaging biomarkers market, by biomarkers, 2021-2033 (USD Million)
Table 13 UAE imaging biomarkers market, by imaging technology, 2021-2033 (USD Million)
Table 14 UAE imaging biomarkers market, by application, 2021-2033 (USD Million)
Table 15 UAE imaging biomarkers market, by End Use, 2021-2033 (USD Million)
Table 16 Kuwait imaging biomarkers market, by biomarkers, 2021-2033 (USD Million)
Table 17 Kuwait imaging biomarkers market, by imaging technology, 2021-2033 (USD Million)
Table 18 Kuwait imaging biomarkers market, by application, 2021-2033 (USD Million)
Table 19 Kuwait imaging biomarkers market, by End Use, 2021-2033 (USD Million)
Table 20 Oman imaging biomarkers market, by biomarkers, 2021-2033 (USD Million)
Table 21 Oman imaging biomarkers market, by imaging technology, 2021-2033 (USD Million)
Table 22 Oman imaging biomarkers market, by application, 2021-2033 (USD Million)
Table 23 Oman imaging biomarkers market, by End Use, 2021-2033 (USD Million)
Table 24 Qatar imaging biomarkers market, by biomarkers, 2021-2033 (USD Million)
Table 25 Qatar imaging biomarkers market, by imaging technology, 2021-2033 (USD Million)
Table 26 Qatar imaging biomarkers market, by application, 2021-2033 (USD Million)
Table 27 Qatar imaging biomarkers market, by End Use, 2021-2033 (USD Million)
Table 28 Participant's overview
Table 29 Financial performance
Table 30 Key companies undergoing expansions
Table 31 Key companies undergoing acquisitions
Table 32 Key companies undergoing collaborations
Table 33 Key companies launching new products
Table 34 Key companies undertaking other strategies
List of Figures
Figure 1 Imaging Biomarkers market segmentation
Figure 2 Market research process
Figure 3 Data triangulation techniques
Figure 4 Primary research pattern
Figure 5 Market research approaches
Figure 6 Market formulation & validation
Figure 7 Market outlook
Figure 8 Segment snapshot
Figure 9 Competitive landscape snapshot
Figure 10 Parent market outlook
Figure 11 Middle East imaging biomarkers market driver analysis
Figure 12 Middle East imaging biomarkers market restraint analysis
Figure 13 Middle East imaging biomarkers market: Porter's analysis
Figure 14 Middle East imaging biomarkers market: PESTEL analysis
Figure 15 Middle East imaging biomarkers market: Biomarkers outlook and key takeaways
Figure 16 Middle East imaging biomarkers market: Biomarkers market share analysis, 2023-2033
Figure 17 Middle East imaging biomarkers by anatomical biomarkers market, 2021-2033 (USD Million)
Figure 18 Middle East imaging biomarkers by functional biomarkers market, 2021-2033 (USD Million)
Figure 19 Middle East imaging biomarkers by molecular/nuclear biomarkers market, 2021-2033 (USD Million)
Figure 20 Middle East imaging biomarkers, by quantitative, 2021-2033 (USD Million)
Figure 21 Middle East imaging biomarkers, by other market, 2021-2033 (USD Million)
Figure 22 Imaging Biomarkers market: Imaging Technology outlook and key takeaways
Figure 23 Imaging Biomarkers market: Imaging Technology market share analysis, 2023-2033
Figure 24 Middle East imaging biomarkers by therapeutic drug monitoring market, 2021-2033 (USD Million)
Figure 25 Middle East imaging biomarkers by MRI market, 2021-2033 (USD Million)
Figure 26 Middle East imaging biomarkers by CT market, 2021-2033 (USD Million)
Figure 27 Middle East imaging biomarkers by PET market, 2021-2033 (USD Million)
Figure 28 Middle East imaging biomarkers by SPECT market, 2021-2033 (USD Million)
Figure 29 Middle East imaging biomarkers by Ultrasound market, 2021-2033 (USD Million)
Figure 30 Middle East imaging biomarkers by others market, 2021-2033 (USD Million)
Figure 31 Imaging Biomarkers market: Application outlook and key takeaways
Figure 32 Imaging Biomarkers market: Application market share analysis, 2023-2033
Figure 33 Middle East imaging biomarkers by diagnostics market, 2021-2033 (USD Million)
Figure 34 Middle East imaging biomarkers by Drug Discovery & Development market, 2021-2033 (USD Million)
Figure 35 Middle East imaging biomarkers by Personalized Medicine market, 2021-2033 (USD Million)
Figure 36 Middle East imaging biomarkers by Disease Risk Assessment market, 2021-2033 (USD Million)
Figure 37 Middle East imaging biomarkers by others market, 2021-2033 (USD Million)
Figure 38 Imaging Biomarkers market: End Use outlook and key takeaways
Figure 39 Imaging Biomarkers market: End Use market share analysis, 2023-2033
Figure 40 Middle East imaging biomarkers by hospitals market, 2021-2033 (USD Million)
Figure 41 Middle East imaging biomarkers by diagnostics centres market, 2021-2033 (USD Million)
Figure 42 Middle East imaging biomarkers by pharmaceutical and biotech companies market, 2021-2033 (USD Million)
Figure 43 Middle East imaging biomarkers by others market, 2021-2033 (USD Million)
Figure 44 Middle East imaging biomarkers market estimates and forecast, 2021-2033 (USD Million)
Figure 45 Saudi Arabia imaging biomarkers market estimates and forecast, 2021-2033 (USD Million)
Figure 46 UAE imaging biomarkers market estimates and forecast, 2021-2033 (USD Million)
Figure 47 Kuwait imaging biomarkers market estimates and forecast, 2021-2033 (USD Million)
Figure 48 Qatar imaging biomarkers market estimates and forecast, 2021-2033 (USD Million)
Figure 49 Oman imaging biomarkers market estimates and forecast, 2021-2033 (USD Million)
Figure 50 Key company categorization
Figure 51 Company market positioning
Figure 52 Market participant categorization
Figure 53 Strategy framework

Companies Mentioned

The key companies profiled in this Middle East Imaging Biomarkers market report include:
  • GE HealthCare
  • FUJIFILM Holdings Corporation
  • Siemens Healthineers AG
  • Lunit Inc.
  • Median Technologies
  • BioClinica Inc.
  • ICON plc
  • Bracco
  • Philips Healthcare

Table Information

Report AttributeDetails
No. of Pages120
PublishedNovember 2025
Forecast Period2024 - 2033
Estimated Market Value ( USD ) in 2024 $ 413.74 Million
Forecasted Market Value ( USD ) by 2033 $ 1130 Million
Compound Annual Growth Rate12.2%
Regions CoveredMiddle East
No. of Companies Mentioned10

Related Topics

Related Reports

Imaging Biomarkers Market Forecast to 2033 - Product Image

Imaging Biomarkers Market Forecast to 2033

  • Report
  • 120 Pages
  • Global
From
Hepatic Fibrosis Biomarkers Market Size, Share & Trends Analysis Report by Product (Blood-based Kits, Saliva-based Kits), by Technology (Immunofiltration Assays, Lateral Flow Assays), by End Use, by Region, and Segment Forecasts, 2025-2033 - Product Image

Hepatic Fibrosis Biomarkers Market Size, Share & Trends Analysis Report by Product (Blood-based Kits, Saliva-based Kits), by Technology (Immunofiltration Assays, Lateral Flow Assays), by End Use, by Region, and Segment Forecasts, 2025-2033

  • Report
  • 150 Pages
  • Global
From
Middle East & Africa Blood-based Biomarker for Alzheimer's Disease Diagnostics Market Size, Share & Trends Analysis Report by Type (Amyloid-related Markers, Tau-related Markers), by Technology, by End-use, by Country, and Segment Forecasts, 2025-2033 - Product Image

Middle East & Africa Blood-based Biomarker for Alzheimer's Disease Diagnostics Market Size, Share & Trends Analysis Report by Type (Amyloid-related Markers, Tau-related Markers), by Technology, by End-use, by Country, and Segment Forecasts, 2025-2033

  • Report
  • 150 Pages
  • Africa, Middle East
From
Neurological Biomarkers Market Size, Share, Trends and Forecast by Type, Application, End Use, and Region, 2025-2033 - Product Image

Neurological Biomarkers Market Size, Share, Trends and Forecast by Type, Application, End Use, and Region, 2025-2033

  • Report
  • 147 Pages
  • Global
From
Cancer Biomarkers Market Report by Profiling Technology, Biomolecule, Cancer Type, Application, End User, and Region 2025-2033 - Product Image

Cancer Biomarkers Market Report by Profiling Technology, Biomolecule, Cancer Type, Application, End User, and Region 2025-2033

  • Report
  • 140 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.